Work

Impact of systemic delays in targeted therapy (TT) access for advanced NSCLC (aNCSLC) with actionable genomic alterations (AGA+) in Alberta, Canada.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.e23028

Authors: Vishal Navani, Amanda Williams Gibson, Michelle Liane Dean, Mobolaji Bosede, Carla Pires Amaro, Rodrigo Rigo, Randeep S. Sangha, Doreen Ezeife

Institutions: Alberta Health Services, University of Calgary, Arthur J.E. Child Comprehensive Cancer Centre, Cross Cancer Institute

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162681908

Cites:

Cited by:

Related to: